SCHEMBL8501160

SCHEMBL8501160

CC(C)[C@@H](NC[C@H](O)[CH]Cc1ccccc1)S(=O)(=O)c1ccc2nc(N)sc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
CYP3A4 P08684 4/20 0.44
CYP2C9 P11712 3/20 0.44
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 4/20 0.42
HSD17B10 Q99714 3/20 0.42
LMNA P02545 3/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
CYP2C19 P33261 2/20 0.40
MEN1 O00255 3/20 0.39
MAPT P10636 2/20 0.38
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
VDR P11473 1/20 0.37
GFER P55789 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13673916 0.93 CYP2D6 (0.41) CYP2D6CYP3A4CYP2C9ALDH1A1KMT2A
SCHEMBL13673882 0.84 RIPK1 (0.38) ALDH1A1KMT2AKDM4EPKMMEN1
SCHEMBL8198204 0.81 CX3CR1 (0.33) CYP2D6
SCHEMBL7453537 0.81 PRMT1 (0.37) ALDH1A1KMT2ALMNAMEN1NPC1
SCHEMBL8024734 0.81 PRMT1 (0.37) ALDH1A1KMT2ALMNAMEN1NPC1
SCHEMBL7453235 0.80 PRMT1 (0.40) ALDH1A1HSD17B10LMNA
SCHEMBL7453483 0.79 ALDH1A1 (0.38) CYP2C9ALDH1A1HSD17B10LMNAHPGD
SCHEMBL2582265 0.78 CYP2D6 (0.51) CYP2D6CYP3A4CYP2C9ALDH1A1KMT2A
SCHEMBL2582026 0.77 ESR1 (0.36) CYP2D6CYP3A4ALDH1A1LMNACYP2C19
SCHEMBL8900553 0.77 CYP3A4 (0.44) CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE43802-E1 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE LLC (US) 2012-11-13 US disclosed
US-5968970-A TREATMENT OF HIV G. D. SEARLE & COMPANY (US) 1999-10-19 US disclosed